CRBG Corebridge Financial, Inc.
Life Insurance · NYSE · SEC CIK 1889539 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $6.16B | $3.91B | $3.96B | $6.77B | $5.42B | $2.73B | $3.57B | $6.60B |
| SG&A expense | $450.00M | $466.00M | $468.00M | $478.00M | $481.00M | $517.00M | $526.00M | $475.00M |
| Interest expense | $134.00M | $131.00M | $131.00M | $132.00M | $135.00M | $137.00M | $148.00M | $145.00M |
| Pretax income | $2.32B | $52.00M | $97.00M | $971.00M | -$42.00M | -$608.00M | -$862.00M | $2.92B |
| Income tax | $880.00M | $50.00M | $158.00M | $173.00M | -$179.00M | $60.00M | -$205.00M | $703.00M |
| Net income | $1.44B | $2.00M | -$53.00M | $814.00M | $144.00M | -$660.00M | -$664.00M | $2.17B |
| EPS (basic) | 3.23 | -0.04 | -0.11 | — | 0.27 | -1.20 | -1.19 | — |
| EPS (diluted) | 3.22 | -0.04 | -0.11 | — | 0.27 | -1.20 | -1.19 | — |
| Dividends declared per share | 0.25 | 0.25 | 0.25 | 0.24 | 0.24 | 0.24 | 0.24 | 0.23 |
| Weighted avg. shares (diluted) | 447.20M | 454.20M | 473.50M | — | 540.60M | 550.30M | 558.00M | — |
| Banking | ||||||||
| Loans, net | $54.38B | $53.86B | $54.35B | $54.48B | $53.96B | $54.33B | $53.33B | $52.77B |
| Balance sheet | ||||||||
| Cash & equivalents | $457.00M | $358.00M | $378.00M | $453.00M | $322.00M | $296.00M | $399.00M | $824.00M |
| Total assets | $404.07B | $415.79B | $407.06B | $413.55B | $411.29B | $399.16B | $390.02B | $389.40B |
| Short-term debt | $1.25B | $1.25B | — | $0 | $0 | $101.00M | $1.10B | $1.10B |
| Total liabilities | $396.64B | $404.42B | $395.52B | $399.59B | $396.97B | $385.99B | $377.19B | $377.07B |
| Shareholders' equity | $6.73B | $10.65B | $10.80B | $13.20B | $13.54B | $12.30B | $11.98B | $11.46B |
| Shares outstanding | 440.31M | 445.77M | 456.73M | 496.37M | 532.11M | 543.19M | 553.10M | 561.49M |
| Cash flow statement | ||||||||
| Operating cash flow | $605.00M | -$44.00M | -$9.00M | $1.88B | $24.00M | -$259.00M | $375.00M | $1.48B |
| Investing cash flow | -$2.74B | $1.56B | -$2.53B | -$3.47B | -$3.32B | -$2.67B | -$3.87B | -$1.35B |
| Financing cash flow | $2.23B | -$1.54B | $2.47B | $1.72B | $3.32B | $2.83B | $3.07B | $146.00M |
| Depreciation & amortization | $194.00M | $173.00M | $165.00M | $174.00M | $199.00M | $94.00M | $89.00M | $61.00M |
| Dividends paid | $110.00M | $112.00M | $114.00M | $119.00M | $128.00M | $131.00M | $133.00M | $129.00M |
| Share buybacks | $185.00M | $300.00M | $1.25B | $1.11B | $380.00M | $311.00M | $321.00M | $398.00M |
Free plan shows the latest 8 periods; Pro shows all 21 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.